Dr. Reddy's Laboratories Limited (BOM:500124)
India · Delayed Price · Currency is INR 1,224.50
-14.50 (-1.17%)
At close: Oct 23, 2026
Dr. Reddy's Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,019,989 | 1,044,616 | 953,168 | 1,024,969 | 767,655 | 714,500 | |
Market Cap Growth | -4.98% | 9.59% | -7.00% | 33.52% | 7.44% | -4.65% |
Enterprise Value | 1,013,821 | 1,033,149 | 948,175 | 972,270 | 736,818 | 707,464 |
Last Close Price | 1224.50 | 1246.75 | 1129.68 | 1208.41 | 900.28 | 832.98 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 36.46 | 24.38 | 16.86 | 18.41 | 17.03 | 30.32 |
Forward PE | 23.84 | 21.35 | 15.36 | 19.12 | 19.56 | 23.75 |
PS Ratio | 3.09 | 3.11 | 2.93 | 3.67 | 3.12 | 3.33 |
PB Ratio | 2.62 | 2.75 | 2.83 | 3.65 | 3.32 | 3.75 |
P/TBV Ratio | 3.79 | 4.03 | 4.24 | 4.28 | 3.92 | 4.50 |
P/FCF Ratio | 73.69 | 31.25 | 50.37 | 35.31 | 16.14 | 53.13 |
P/OCF Ratio | 33.00 | 18.41 | 20.53 | 22.56 | 13.04 | 25.42 |
PEG Ratio | 6.07 | 6.75 | 2.87 | 1.13 | 0.95 | 1.13 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.07 | 3.08 | 2.91 | 3.48 | 3.00 | 3.30 |
EV/EBITDA Ratio | 19.64 | 15.16 | 10.80 | 12.31 | 11.16 | 14.82 |
EV/EBIT Ratio | 33.57 | 20.98 | 13.17 | 14.89 | 13.79 | 19.70 |
EV/FCF Ratio | 73.24 | 30.91 | 50.10 | 33.49 | 15.50 | 52.61 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.19 | 0.20 | 0.14 | 0.07 | 0.06 | 0.18 |
Debt / EBITDA Ratio | 1.40 | 1.11 | 0.53 | 0.25 | 0.20 | 0.71 |
Debt / FCF Ratio | 5.22 | 2.31 | 2.47 | 0.69 | 0.28 | 2.52 |
Net Debt / Equity Ratio | -0.01 | -0.03 | -0.03 | -0.22 | -0.21 | -0.05 |
Net Debt / EBITDA Ratio | -0.08 | -0.15 | -0.13 | -0.78 | -0.73 | -0.22 |
Net Debt / FCF Ratio | -0.29 | -0.31 | -0.59 | -2.12 | -1.02 | -0.78 |
Asset Turnover | 0.59 | 0.63 | 0.74 | 0.79 | 0.80 | 0.77 |
Inventory Turnover | 2.12 | 2.15 | 2.01 | 2.06 | 2.14 | 2.09 |
Quick Ratio | 1.15 | 1.13 | 1.16 | 1.72 | 1.58 | 1.24 |
Current Ratio | 1.93 | 1.80 | 1.92 | 2.58 | 2.38 | 1.93 |
Return on Equity (ROE) | 7.34% | 11.83% | 18.53% | 21.77% | 21.38% | 12.96% |
Return on Assets (ROA) | 3.38% | 5.74% | 10.22% | 11.51% | 10.86% | 8.04% |
Return on Invested Capital (ROIC) | 6.20% | 10.96% | 19.70% | 25.19% | 21.99% | 15.03% |
Return on Capital Employed (ROCE) | 7.20% | 12.00% | 19.90% | 22.40% | 22.60% | 18.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.74% | 4.10% | 5.93% | 5.43% | 5.87% | 3.30% |
FCF Yield | 1.36% | 3.20% | 1.98% | 2.83% | 6.19% | 1.88% |
Dividend Yield | 0.65% | 0.64% | 0.70% | 0.65% | 0.87% | 0.70% |
Payout Ratio | 23.81% | 15.54% | 11.78% | 11.94% | 11.05% | 17.59% |
Buyback Yield / Dilution | -0.01% | 0.10% | -0.08% | -0.19% | -0.03% | -0.01% |
Total Shareholder Return | 0.65% | 0.74% | 0.62% | 0.46% | 0.84% | 0.68% |